News

In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the leading cause of hospitalization for...

Thoratec Corp. has acquired Apica Cardiovascular Ltd. for an upfront cash payment of $35 million and potential future clinical and sales milestones of up to $40 million. 

Revivent Myocardial Anchoring System BioVentrix 50th Heart Failure Treatment

BioVentrix announced the successful completion of it 50th clinical case using the Revivent myocardial anchoring system in a 74-year-old male patient at the OLV Hospital in Aalst, Belgium....

June 23, 2014 — Men who reported being sedentary, with low levels of physical activity, were at a significantly higher risk for heart failure than those who were more active, according to a Kaiser...

Watchman, LAA occluder

Interventional thought leaders at the American College of Cardiology (ACC) 2014 meeting shared their predictions about the cutting-edge technologies emerging today that will become commonplace in...

Mast Therapeutics Failure MST-188 Clinical Study Pharmaceuticals

Mast Therapeutics Inc. announced that, in a placebo-controlled, nonclinical model of chronic heart failure, MST-188 demonstrated a statistically significant improvement in numerous parameters of...

St. Jude Medical announced the completion of its acquisition of the privately held CardioMEMS Inc., developer of the CardioMEMS heart failure (HF) management system. The acquisition was...

CardioMEMS Heart Failure System FDA Approval

The U.S. Food and Drug Administration (FDA) granted market clearance to the CardioMEMS Heart Failure System, the first FDA-approved heart failure (HF) monitoring device shown in clinical trials to...

May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-defibrillators (ICDs) can safely extend...

ICD Implants Heart Rhythm Society Clinical Study Insurance Male

A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance disparities in implantable...

Hospira Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot number...

HeartWare Ltd. Ventricular Assist Device Correction Batteries

HeartWare Intl. Inc. issued a voluntary Urgent Medical Device Correction related to all HeartWare Ventricular Assist System batteries, product codes 1650 and 1650-DE. 

April 30, 2014 — Celladon Corp. announced its lead product candidate, Mydicar, has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for reducing...

Advanced Visualization Artificial Hear Heart Repair Arizona State University

An Arizona State University research group and medical professionals at Phoenix Children’s Hospital are achieving some firsts in the history of artificial heart implantation.

heartware lvads vanderbilt heart heartmate

April 25, 2014 — Vanderbilt Heart and Vascular Institute (VHVI) was the first facility in Tennessee to implant the miniaturized HeartWare HVAD pump through a minimally invasive approach known as a...

April 24, 2014 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for its latest generation of defibrillators and heart failure devices. The newly approved...

April 23, 2014 — The PROCEED II heart transplant U.S. Food and Drug Administration (FDA) pivotal trial results using the Organ Care System (OCS) Heart platform were announced at the International...

April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become the clinical gold standard in the treatment of chronic heart failure (...

Cytori Stem Cell Therapy Heart Failure Treatments PRECISE Trial

Cytori Therapeutics announced publication of safety and efficacy data from a 36 month European clinical trial of Cytori Cell Therapy in patients with chronic ischemic heart failure. 

April 18, 2014 — New research presented at the 34th annual meeting of the International Society for Heart and Lung Transplantation (ISHLT) demonstrated the CorMatrix particulate extracellular...